ADENURIC

Found in: Austria Australia Cyprus Spain France Netherlands United Kingdom

Active Ingredients

Febuxostat

Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.

ATC Classification

M04AA03

Febuxostat

M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production

Product Monographs

ADENURIC Film-coated tablet

MPI, EU: SmPC

Identifiers

Pharmaceutical Benefits Scheme (AU)

Identifier(s): 10445R

Z-Index G-Standaard PRK (NL)

Identifier(s): 101788, 101796

Base de données publique des médicaments (FR)

Identifier(s): 61871331, 64493890

Centro de información online de medicamentos de la AEMPS (ES)

Identifier(s): 08447001, 08447003